CRISPR/Cas System: A Potential Technology for the Prevention and Control of COVID-19 and Emerging Infectious Diseases.

Frontiers in Cellular and Infection Microbiology
Ronghua DingGuangcai Duan

Abstract

The continued global pandemic of coronavirus disease 2019 (COVID-19) poses a serious threat to global public health and social stability and it has become a serious global public health problem. Unfortunately, existing diagnostic and therapeutic approaches for the prevention and control of COVID-19 have many shortcomings. In recent years, the emerging CRISPR/Cas technology can complement the problems of traditional methods. Biological tools based on CRISPR/Cas systems have been widely used in biomedicine. In particular, they are advantageous in pathogen detection, clinical antiviral therapy, drug, and vaccine development. Therefore, CRISPR/Cas technology may have great potential for application in the prevention and control of COVID-19 and emerging infectious diseases in the future. This article summarizes the existing applications of CRISPR/Cas technology in infectious diseases with the aim of providing effective strategies for the prevention and control of COVID-19 and other emerging infectious diseases in the future.

References

Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·D R ThickettA B Millar
Jan 15, 2010·Nature·Luciano A Marraffini, Erik J Sontheimer
Dec 18, 2012·Nature·Joe Bondy-DenomyAlan R Davidson
Jun 25, 2013·Nature Biotechnology·Yanfang FuJeffry D Sander
Aug 27, 2013·Scientific Reports·Hirotaka EbinaYoshio Koyanagi
Jul 23, 2014·Proceedings of the National Academy of Sciences of the United States of America·Wenhui HuKamel Khalili
Apr 15, 2017·Science·Jonathan S GootenbergFeng Zhang
Jun 13, 2017·Current Opinion in Microbiology·Eugene V KooninFeng Zhang
Aug 29, 2017·Cell·Lucas B HarringtonJennifer A Doudna
Sep 21, 2017·Nature·Janice S ChenJennifer A Doudna
Nov 22, 2017·Journal of Human Genetics·Morito KurataDavid A Largaespada
Jan 7, 2018·Trends in Biotechnology·Zachary GlassQiaobing Xu
Feb 9, 2018·ELife·Jeffrey SettlemanTony Hunter
Feb 24, 2018·Genome Research·Sojung KimJin-Soo Kim
Jun 10, 2018·Journal of Molecular Biology·Carolyn Brokowski, Mazhar Adli
Sep 1, 2018·Science·Hiroshi NishimasuOsamu Nureki
Sep 1, 2018·Science·Gavin J Knott, Jennifer A Doudna
Oct 20, 2018·Science·Lucas B HarringtonJennifer A Doudna
Oct 20, 2018·Journal of Cellular and Molecular Medicine·Li ZhouJinming Li
Nov 30, 2018·Journal of Hematology & Oncology·Juanjuan ZhaoDelong Liu
Jan 1, 2019·Molecular Cell·Fuguo JiangJennifer A Doudna
Mar 31, 2019·Biotechnology Advances·Fei WangShi Chen
Apr 12, 2019·Nature·Fiona M BehanMathew J Garnett
Apr 24, 2019·Nature Biomedical Engineering·Louai LabaniehCrystal L Mackall
May 31, 2019·Nature Reviews. Molecular Cell Biology·Adrian Pickar-Oliver, Charles A Gersbach
Aug 31, 2019·Cell Biology and Toxicology·Fancheng YanJiaqiang Zhang
Oct 15, 2019·Molecular Cell·Catherine A FreijePardis C Sabeti
Jan 30, 2020·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Victor M CormanChristian Drosten

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.